Bandini, Lavinia Statistiche
Bandini, Lavinia
Exogenous 3-Iodothyronamine (T1AM) Can Affect Phosphorylation of Proteins Involved on Signal Transduction Pathways in In Vitro Models of Brain Cell Lines, but These Effects Are Not Strengthened by Its Catabolite, 3-Iodothyroacetic Acid (TA1)
2022-01-01 Bandini, Lavinia; Sacripanti, Ginevra; Borsò, Marco; Tartaria, Maria; Fogliaro, Maria Pia; Giannini, Giulia; Carnicelli, Vittoria; Figuccia, Matteo Emanuele; Verlotta, Sara; De Antoni, Fiammetta; Zucchi, Riccardo; Ghelardoni, Sandra
Delivery of thyronamines (Tams) to the brain: A preliminary study
2021-01-01 Di Leo, N.; Moscato, S.; Borso', M.; Sestito, S.; Polini, B.; Bandini, L.; Grillone, A.; Battaglini, M.; Saba, A.; Mattii, L.; Ciofani, G.; Chiellini, G.
The 3-iodothyroacetic acid does not cause change in proteins affected by T1AM.
2021-01-01 Bandini, L.; Borsò, M.; Verlotta, S.; Figuccia, M. E.; Ghelardoni, S.
3-Iodothyronamine and 3,5,3’-triiodo-L-thyronine reduce SIRT1 protein expression in HepG2 cell line.
2020-01-01 Sacripanti, Ginevra; Lorenzini, Leonardo; Bandini, Lavinia; Frascarelli, Sabina; Zucchi, Riccardo; Ghelardoni, Sandra
3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome?
2020-01-01 Rutigliano, Grazia; Bandini, Lavinia; Sestito, Simona; Chiellini, Grazia
ACE2 in the era of SARS-CoV-2: controversies and novel perspectives
2020-01-01 Saponaro, Federica; Rutigliano, Grazia; Sestito, Simona; Bandini, Lavinia; Storti, Barbara; Bizzarri, Ranieri; Zucchi, Riccardo
Exogenous 3-iodothyronamine rescues the entorhinal cortex from β-amyloid toxicity
2020-01-01 Accorroni, Alice; Rutigliano, Grazia; Sabatini, Martina; Frascarelli, Sabina; Borsò, Marco; Novelli, Elena; Bandini, Lavinia; Ghelardoni, Sandra; Saba, Alessandro; Zucchi, Riccardo; Origlia, Nicola
SUN-717 SG-2 a Novel Multi-Target Directed Ligand (MTDL) for the Treatment of Neurodegenerative Diseases (NDDS)
2020-01-01 Chiellini, Grazia; Rapposelli, Simona; Origlia, Nicola; Santucci, Filippo; Bandini, Lavinia; Runfola, Massimiliano; Sestito, Simona
3-iodothyronamine (T1AM) is taken up and rapidly metabolized in neuronal cells
2019-01-01 Saponaro, Federica; Borsò, Marco; Verlotta, Sara; Bandini, Lavinia; Saba, Alessandro; Zucchi, Riccardo; Ghelardoni, Sandra
3-iodothyronamine (T1AM) induces changes on glutamatergic postsynaptic signaling pathway
2019-01-01 Bandini, Lavinia; Sacripanti, Ginevra; Figuccia Matteo, Emanuele; Verlotta, Sara; Zucchi, Riccardo; Ghelardoni, Sandra
Effects of 3-iodothyronamine (T1AM) on long term potentiation (LTP) postsynaptic signaling cascade
2018-01-01 Sacripanti, Ginevra; Bandini, Lavinia; Pia Fogliaro, Maria; Giannini, Giulia; Lorenzini, Leonardo; Zucchi, Riccardo; Ghelardoni, Sandra
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Exogenous 3-Iodothyronamine (T1AM) Can Affect Phosphorylation of Proteins Involved on Signal Transduction Pathways in In Vitro Models of Brain Cell Lines, but These Effects Are Not Strengthened by Its Catabolite, 3-Iodothyroacetic Acid (TA1) | 1-gen-2022 | Bandini, Lavinia; Sacripanti, Ginevra; Borsò, Marco; Tartaria, Maria; Fogliaro, Maria Pia; Giannini, Giulia; Carnicelli, Vittoria; Figuccia, Matteo Emanuele; Verlotta, Sara; De Antoni, Fiammetta; Zucchi, Riccardo; Ghelardoni, Sandra | |
| Delivery of thyronamines (Tams) to the brain: A preliminary study | 1-gen-2021 | Di Leo, N.; Moscato, S.; Borso', M.; Sestito, S.; Polini, B.; Bandini, L.; Grillone, A.; Battaglini, M.; Saba, A.; Mattii, L.; Ciofani, G.; Chiellini, G. | |
| The 3-iodothyroacetic acid does not cause change in proteins affected by T1AM. | 1-gen-2021 | Bandini, L.; Borsò, M.; Verlotta, S.; Figuccia, M. E.; Ghelardoni, S. | |
| 3-Iodothyronamine and 3,5,3’-triiodo-L-thyronine reduce SIRT1 protein expression in HepG2 cell line. | 1-gen-2020 | Sacripanti, Ginevra; Lorenzini, Leonardo; Bandini, Lavinia; Frascarelli, Sabina; Zucchi, Riccardo; Ghelardoni, Sandra | |
| 3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome? | 1-gen-2020 | Rutigliano, Grazia; Bandini, Lavinia; Sestito, Simona; Chiellini, Grazia | |
| ACE2 in the era of SARS-CoV-2: controversies and novel perspectives | 1-gen-2020 | Saponaro, Federica; Rutigliano, Grazia; Sestito, Simona; Bandini, Lavinia; Storti, Barbara; Bizzarri, Ranieri; Zucchi, Riccardo | |
| Exogenous 3-iodothyronamine rescues the entorhinal cortex from β-amyloid toxicity | 1-gen-2020 | Accorroni, Alice; Rutigliano, Grazia; Sabatini, Martina; Frascarelli, Sabina; Borsò, Marco; Novelli, Elena; Bandini, Lavinia; Ghelardoni, Sandra; Saba, Alessandro; Zucchi, Riccardo; Origlia, Nicola | |
| SUN-717 SG-2 a Novel Multi-Target Directed Ligand (MTDL) for the Treatment of Neurodegenerative Diseases (NDDS) | 1-gen-2020 | Chiellini, Grazia; Rapposelli, Simona; Origlia, Nicola; Santucci, Filippo; Bandini, Lavinia; Runfola, Massimiliano; Sestito, Simona | |
| 3-iodothyronamine (T1AM) is taken up and rapidly metabolized in neuronal cells | 1-gen-2019 | Saponaro, Federica; Borsò, Marco; Verlotta, Sara; Bandini, Lavinia; Saba, Alessandro; Zucchi, Riccardo; Ghelardoni, Sandra | |
| 3-iodothyronamine (T1AM) induces changes on glutamatergic postsynaptic signaling pathway | 1-gen-2019 | Bandini, Lavinia; Sacripanti, Ginevra; Figuccia Matteo, Emanuele; Verlotta, Sara; Zucchi, Riccardo; Ghelardoni, Sandra | |
| Effects of 3-iodothyronamine (T1AM) on long term potentiation (LTP) postsynaptic signaling cascade | 1-gen-2018 | Sacripanti, Ginevra; Bandini, Lavinia; Pia Fogliaro, Maria; Giannini, Giulia; Lorenzini, Leonardo; Zucchi, Riccardo; Ghelardoni, Sandra |